Novetide Ltd.

Novetide Ltd. is a leading pharmaceutical manufacturing company specializing in the research, development, manufacturing, and marketing of peptide-based drug substances. Novetide's technology platform utilizes several unique technologies and a wealth of know-how for peptide development and production, encompassing sequence assembly, downstream processing, characterization, and documentation of peptide drug substances. The company's significant investment in research and development ensures a continuous flow of innovative products, enabling the timely introduction of pharmaceutical products to the market.

Novetide offers a comprehensive portfolio of proprietary custom manufactured products suitable for clinical development and commercial supply. The company also provides multi-source products such as Atosiban, Bivalirudin, Degarelix, Desmopressin, Eptifibatide, Exenatide, Goserelin, Lanreotide, Leuprolide, Octreotide, Pramlintide, Teriparatide (PTH 1-34), Triptorelin Acetate, and Triptorelin Pamoate. Novetide operates from its primary address at POB 10140, Haifa, 26111, IL. The company’s management will soon complete further details about Novetide.

Committed to supporting its customers through the entire development pathway, Novetide provides regulatory support, DMF submission, IP management, and large-scale commercial quantities. With cutting-edge technologies and state-of-the-art computerized systems at two FDA-inspected manufacturing facilities, Novetide maintains consistently high product quality while continuously improving productivity and reliability. The production capacity ranges from grams to hundreds of kilograms. We invite the manager of Novetide Ltd. to create a customized and exclusive company showcase and product listing on our platform.